Rajshree Patel ceases as Independent Director at Advanced Enzyme Technologies

Rajshree Patel ceased to be an Independent Director at Advanced Enzyme Technologies Ltd on June 11, 2026, upon the completion of her second consecutive term. The change in the board composition was effective from the end of business hours on June 11, 2026.

The company informed the stock exchanges regarding the cessation of the director pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. The disclosure was also made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated July 11, 2023, as updated on January 30, 2026.

Details of Cessation

The following table outlines the specific details regarding the change in directorship:

Particulars	Details
Name of Director	Ms. Rajshree Patel (DIN – 08761022)
Reason for Cessation	Completion of second term as an Independent Director
Date of Cessation	June 11, 2026
Effective Time	End of business hours

The filing was submitted by Sanjay Basantani, Company Secretary and Head – Legal, on behalf of Advanced Enzyme Technologies Ltd .

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.74%	-2.34%	-5.81%	+20.26%	+10.50%	-11.14%

Advanced Enzyme Technologies Limited has increased its stake in its wholly owned subsidiary, Advanced Nutrazyme Private Limited (ANPL), through an additional investment of ₹2.5 million. The company completed this transaction by subscribing to a rights issue of 2,50,000 equity shares with a face value of ₹10 each. This move strengthens the parent company's financial commitment to its subsidiary.

With this infusion, the total investment in ANPL has risen to ₹3 million. This capital is divided into 3,00,000 equity shares of ₹10 each, consolidating Advanced Enzyme Technologies' ownership position. The rights issue serves as a mechanism for the subsidiary to raise capital directly from its existing shareholder.

Investment Details

The transaction details regarding the additional investment are outlined below:

Description	Details
Investment Amount	₹2.5 million
Shares Subscribed	2,50,000 Equity Shares
Face Value	₹10 each
Total Post-Investment Holding	₹3 million
Total Shares Held	3,00,000 Equity Shares

The disclosure was filed with the stock exchanges on June 06, 2026. The intimation references a prior letter dated August 02, 2025, regarding the proposed investment. The filing was signed by Sanjay Basantani, Company Secretary and Head – Legal.